Skip to content

IN2PHARMA

Active
Public limited companyfounded 200818 yrs activeTerloonststraat 22, 1910 Kampenhout, BelgiumKBO/BCE: BE 0895.730.662
Summary

IN2PHARMA has been active since 2008 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €69,300 and a net result of €984,888. Equity remains stable across the filed fiscal years (±0% per year). Its solvency ranks better than 10% of 8113 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.2% (very low).

Checked score

Score 2024
Axes · tick = 2023
Profitability100=
Solvency30=
Growth68=
Track record100
Bankruptcy probability, 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €4,000 at 30 days acceptable
Liquidity tight (current ratio 1.06 against 1.05 in 2023; short-term debt: 94.6% and cash: 9.8% of total assets), and 94.8% of the assets are financed with debt.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 70
Relative position
BE, all sectors
reference
Activities of head offices; management consultancy activities (NACE 70)
about 69% fewer bankruptcies
← fewer bankruptcies more bankruptcies →
raises risk · Multiple establishment units
Several establishment units mean more fixed costs, and such companies fail more often than a company with one establishment.
KBO · establishment units
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 18 years 0 20 y
lowers risk · Lower-risk legal form
Companies with this legal form statistically fail less often than a BV.
KBO · legal form
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 10% of 8113 sector peers (2024).
NBB · sector comparison
Position among 8113 sector peers
Solvency
better than 10%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 10-07-2025, 21 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
not confirmed
2024
21 d early
2023
77 d early
2022
13 d early
2021
138 d early
2020
116 d early
2019
95 d early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 6 accounts on average 77 days before the deadline; the sector median for financial year 2024 is 9 days before the deadline, and 32% of the sector filed late.

Checked, nothing found (1)
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

On 29 January 2008, IN2PHARMA was incorporated.1 Total assets went from EUR 610,151 in 2018 to EUR 1.3 million in 2024 and headcount from 6.8 to 11.3 full-time equivalents.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2018 and 2024

Go further with this company

Is this your company? See how customers and banks see it.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2024, abbreviated schema

Equity
€69,300=
2023 · €69,300
Total assets
€1.3m▼ 10.2%
2023 · €1.5m
Net result
€984,888▼ 13.6%
2023 · €1.1m
Working capital
€70,753▲ 4.5%
2023 · €67,712
Trend over the years

Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 70, Activities of head offices; management consultancy activities, each year against the same schema; no band under 30 filings. Dashed line: the median.

Every figure with its change against the fiscal year before
favourable unfavourable
Line20202021202220232024
Operating result€702,507▼ 1.3%€705,751▲ 0.5%€928,727▲ 31.6%€1.1m▲ 20.1%€987,561▼ 11.5%
Net result€699,310above the sector's middle half▼ 1.0%€702,210above the sector's middle half▲ 0.4%€939,127above the sector's middle half▲ 33.7%€1.1mabove the sector's middle half▲ 21.4%€984,888above the sector's middle half▼ 13.6%
Equity€69,300below the sector's middle half=€69,300below the sector's middle half=€69,300below the sector's middle half=€69,300below the sector's middle half=€69,300below the sector's middle half=
Total assets€967,881within the sector's middle half▲ 1.9%€857,036within the sector's middle half▼ 11.5%€1.2mwithin the sector's middle half▲ 39.4%€1.5mwithin the sector's middle half▲ 24.3%€1.3mwithin the sector's middle half▼ 10.2%
Debt€898,581▲ 2.0%€787,736▼ 12.3%€1.1m▲ 42.9%€1.4m▲ 25.8%€1.3m▼ 10.7%
Working capital€68,022within the sector's middle half▼ 1.5%€68,060within the sector's middle half▲ 0.1%€69,300within the sector's middle half▲ 1.8%€67,712within the sector's middle half▼ 2.3%€70,753within the sector's middle half▲ 4.5%
Solvency7.2%below the sector's middle half▼ 0.1pp8.1%below the sector's middle half▲ 0.9pp5.8%below the sector's middle half▼ 2.3pp4.7%below the sector's middle half▼ 1.1pp5.2%below the sector's middle half▲ 0.5pp
Current ratio1.08within the sector's middle half=1.09within the sector's middle half▲ 0.011.06within the sector's middle half▼ 0.021.05within the sector's middle half▼ 0.011.06within the sector's middle half▲ 0.01
Return on assets (ROA)72.3%above the sector's middle half▼ 2.1pp81.9%above the sector's middle half▲ 9.7pp78.6%above the sector's middle half▼ 3.3pp76.7%above the sector's middle half▼ 1.9pp73.8%above the sector's middle half▼ 2.9pp
Staff (FTE)8.2above the sector's middle half▲ 3.8%8.8above the sector's middle half▲ 7.3%8.9above the sector's middle half▲ 1.1%8.6above the sector's middle half▼ 3.4%11.3above the sector's middle half▲ 31.4%
above within below the middle half (P25 to P75) of NACE 70, Activities of head offices; management consultancy activities, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
€0€500,000€1.0mOperating result 2020: €702,507€702,507Net result 2020: €699,310€699,310Operating result 2021: €705,751€705,751Net result 2021: €702,210€702,210Operating result 2022: €928,727€928,727Net result 2022: €939,127€939,127Operating result 2023: €1.1m€1.1mNet result 2023: €1.1m€1.1mOperating result 2024: €987,561€987,561Net result 2024: €984,888€984,88820202021202220232024€0€500,000€1mOperating result 2022: €928,727€929,000Net result 2022: €939,127€939,000Operating result 2023: €1.1m€1.1mNet result 2023: €1.1m€1.1mOperating result 2024: €987,561€988,000Net result 2024: €984,888€985,000202220232024
The operating result falls in 2024; 2024 is 11% below 2023.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €1.3m
Fixed assets €974 ▼ 38.7%
Current assets €1.3m ▼ 10.1%
Equity and liabilities €1.3m
Equity €69,300 =
Debt €1.3m ▼ 10.7%
Debt's share of the balance-sheet total falls from 95.3% to 94.8%. Debt is lower.
Key figures and ratios
2024 value · change against 2023
EBITDA
€988,174▼
2023 · €1.1m
Cash flow
€985,502▼
2023 · €1.1m
Debt to equity
18.26▼
2023 · 20.44
Interest coverage
162.99▼
2023 · 417.62
Debt ≤ 1 year
€1.3m▼
2023 · €1.4m
Income taxes
€3,914▼
2023 · €4,646
Staff costs
€851,814▲
2023 · €664,747
A ratio outside any meaningful range has been withheld (balance sheet total €1.3m, equity €69,300).
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 535 companies that looked in July 2024 the way this one looks now, 0.7% went bankrupt within 24 months and 96% are still going.

  • Small
  • 10 to 20 years old
  • solvency under 10%
  • a profit of 5% of the balance sheet or more
0.7% went bankrupt
3.2% stopped otherwise
96% still going

A further 0.2% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a bankruptcy probability of 0.2% over twelve months; the group does not contradict it.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,662 companies of July 2024 its group's bankruptcy share. Expected: 1.5%; actually bankrupt within 24 months: 1.6%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.4%
3 0.5% 0.5%
4 0.6% 0.7%
5 0.8% 0.9%
6 1.2% 1.3%
7 1.5% 1.7%
8 1.7% 1.7%
9 2.7% 2.8%
10 5.3% 5.7%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 75% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 535 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2024 against 2023 · 49 lines
Balance sheet Code20232024
Assets
Total assets20/58€1.5m€1.3m▼
Fixed assets21/28€1,588€974▼
Tangible fixed assets22/27€1,588€974▼
Furniture and vehicles24€1,588€974▼
Current assets29/58€1.5m€1.3m▼
Amounts receivable after more than one year29€201,343€0▼
Other amounts receivable291€201,343€0▼
Amounts receivable within one year40/41€1.2m€1.2m▲
Trade receivables40€576,047€518,107▼
Other amounts receivable41€604,705€683,039▲
Cash at bank and in hand54/58€101,402€130,701▲
Deferred charges and accrued income490/1€489€1,619▲
Equity and liabilities
Total equity and liabilities10/49€1.5m€1.3m▼
Equity10/15€69,300€69,300=
Contributions10/11€63,000€63,000=
Capital10€63,000€63,000=
Issued capital100€63,000€63,000=
Reserves13€6,300€6,300=
Non-distributable reserves130/1€6,300€6,300=
Legal reserve130€6,300€6,300=
Profit (loss) carried forward14€0€0=
Amounts payable17/49€1.4m€1.3m▼
Amounts payable within one year42/48€1.4m€1.3m▼
Trade debts44€119,762€88,326▼
Suppliers440/4€119,762€88,326▼
Taxes, remuneration and social security45€149,865€183,886▲
Taxes450/3€23,277€25,081▲
Remuneration and social security454/9€126,588€158,804▲
Other amounts payable47/48€1.1m€990,501▼
Accrued charges and deferred income492/3-€2,427
Income statement Code20232024
Non-recurring operating income76A€0-
Remuneration, social security and pensions62€664,747€851,814▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€254€614▲
Other operating charges640/8€9,012€61,050▲
Non-recurring operating charges66A€0€4,987▲
Gross operating margin9900€1.8m€1.9m▲
Operating profit (loss)9901€1.1m€987,561▼
Financial income75/76B€31,584€7,305▼
Recurring financial income75€31,584€7,305▼
Financial charges65/66B€2,671€6,063▲
Recurring financial charges65€2,671€6,063▲
Profit (loss) for the period before taxes9903€1.1m€988,802▼
Income taxes67/77€4,646€3,914▼
Profit (loss) for the period9904€1.1m€984,888▼
Profit (loss) for the period to be appropriated9905€1.1m€984,888▼
Appropriation of the result
Profit (loss) to be appropriated9906€1.1m€984,888▼
Profit to be distributed694/7€1.1m€984,888▼
Directors or managers695€1.1m€984,888▼
Social balance
Average headcount (FTE)90878.611.3▲

The notes to these accounts (5 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20202021202220232024Change
Non-recurring operating income76A--€155€0--
Remuneration, social security and pensions62--€513,108€664,747€851,814▲ 28.1%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€509€649€0€254€614▲ 142%
Other operating charges640/8--€27,936€9,012€61,050▲ 577%
Non-recurring operating charges66A--€445€0€4,987-
Gross operating margin9900€1.2m€1.3m€1.5m€1.8m€1.9m▲ 6.5%
Operating profit (loss)9901€702,507€705,751€928,727€1.1m€987,561▼ 11.5%
Financial income75/76B--€13,835€31,584€7,305▼ 76.9%
Recurring financial income75€0€0€13,835€31,584€7,305▼ 76.9%
Financial charges65/66B--€104€2,671€6,063▲ 127%
Recurring financial charges65€142€67€104€2,671€6,063▲ 127%
Profit (loss) for the period before taxes9903€702,366€705,684€942,458€1.1m€988,802▼ 13.6%
Income taxes67/77€3,056€3,474€3,331€4,646€3,914▼ 15.8%
Profit (loss) for the period9904€699,310€702,210€939,127€1.1m€984,888▼ 13.6%
Profit (loss) for the period to be appropriated9905€699,310€702,210€939,127€1.1m€984,888▼ 13.6%
Line20202021202220232024Change
Assets
Total assets20/58€967,881€857,036€1.2m€1.5m€1.3m▼ 10.2%
Fixed assets21/28€1,278€1,240€0€1,588€974▼ 38.7%
Tangible fixed assets22/27€1,278€1,240€0€1,588€974▼ 38.7%
Furniture and vehicles24--€0€1,588€974▼ 38.7%
Current assets29/58€966,602€855,796€1.2m€1.5m€1.3m▼ 10.1%
Amounts receivable after more than one year29---€201,343€0▼ 100%
Other amounts receivable291---€201,343€0▼ 100%
Amounts receivable within one year40/41€568,922€554,694€707,031€1.2m€1.2m▲ 1.7%
Trade receivables40--€578,965€576,047€518,107▼ 10.1%
Other amounts receivable41--€128,066€604,705€683,039▲ 13.0%
Cash at bank and in hand54/58€397,192€300,790€484,462€101,402€130,701▲ 28.9%
Deferred charges and accrued income490/1--€3,267€489€1,619▲ 231%
Equity and liabilities
Total equity and liabilities10/49€967,881€857,036€1.2m€1.5m€1.3m▼ 10.2%
Equity10/15€69,300€69,300€69,300€69,300€69,300=
Contributions10/11€63,000€63,000€63,000€63,000€63,000=
Capital10--€63,000€63,000€63,000=
Issued capital100--€63,000€63,000€63,000=
Reserves13€6,300€6,300€6,300€6,300€6,300=
Non-distributable reserves130/1--€6,300€6,300€6,300=
Legal reserve130--€6,300€6,300€6,300=
Profit (loss) carried forward14--€0€0€0-
Amounts payable17/49€898,581€787,736€1.1m€1.4m€1.3m▼ 10.7%
Amounts payable within one year42/48€898,581€787,736€1.1m€1.4m€1.3m▼ 10.8%
Trade debts44€68,669€20,644€47,225€119,762€88,326▼ 26.2%
Suppliers440/4--€47,225€119,762€88,326▼ 26.2%
Taxes, remuneration and social security45--€124,641€149,865€183,886▲ 22.7%
Taxes450/3--€21,946€23,277€25,081▲ 7.8%
Remuneration and social security454/9--€102,695€126,588€158,804▲ 25.4%
Other amounts payable47/48--€953,594€1.1m€990,501▼ 13.6%
Accrued charges and deferred income492/3----€2,427-
Line20202021202220232024Change
Profit (loss) for the period9904€699,310€702,210€939,127€1.1m€984,888▼ 13.6%
+ Depreciation and write-downs630€509€649€0€254€614▲ 142%
Operating cash flow (approximation)€699,819€702,859€939,127€1.1m€985,502▼ 13.5%
Investment in fixed assets (approximation)--€611€1,240-€1,841€0▲ 100%
Change in cash--€96,403€183,673-€383,061€29,299▲ 108%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

2026
12-02
State Gazette act Restructuring
Merger · Accounting effect · Merger condition8 facts ▸
  • Board meeting, 15-01-2026
  • Merger, sister merger by absorption
  • Merger, sister merger by absorption
  • Accounting effect, 01-01-2026
  • Merger condition, zonder uitreiking van nieuwe aandelen in de Overnemende Vennootschap
  • Tax treatment, WIB art. 211 en volgende; BTW art. 11 en 18, paragraaf 3
  • Personnel transfer, Het personeel van de Over te Nemen Vennootschappen gaat automatisch en van rechtswege over op de Overnemende Vennootschap met naleving van de voorwaarden en de…
  • Real estate, De Over te Nemen Vennootschappen bezitten geen onroerende goederen of onroerende zakelijke rechten in Vlaanderen, Wallonië en/of Brussel.
2025
10-07
NBB filing Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
15-05
NBB filing Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
31-12
Financial Highest result since 2018net €1.1m ▲21.4%
Operating result €1.1m, net result €1.1m, both a record.
18-07
NBB filing Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
15-03
NBB filing Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
06-04
NBB filing Annual accounts filed
fiscal year 2020 · abbreviated schema
2020
27-04
NBB filing Annual accounts filed
fiscal year 2019 · abbreviated schema
2019
31-07
NBB filing Annual accounts filed
fiscal year 2018 · abbreviated schema
2018
31-08
NBB filing Annual accounts filed
fiscal year 2017 · abbreviated schema · 31 days late
2017
31-08
NBB filing Annual accounts filed
fiscal year 2016 · abbreviated schema · 31 days late
2016
28-07
NBB filing Annual accounts filed
fiscal year 2015 · abbreviated schema
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
1 of 9 acts read
About the unread acts

Of the 9 Belgian State Gazette acts we know for this company, 1 has been read. The other 8 have not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
9 acts for this company are in the Belgian State Gazette, of which we have read 1. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Kampenhout · 2 establishment units since 2014
seat establishment All 2 establishment units on the map
Ground area
5,215 m²
Building footprint
2,374 m²
Volume, LiDAR
17,386 m³
2 parcels, Flanders · tallest building 10.0 m, ±3 floors. Linked by address, not a title deed.
6 companies at this address See who is registered here
2 establishment units
IN2PHARMA
Terloonststraat 22, 1910 KampenhoutComputing infrastructure, data processing, hosting and other information service activities
since 20142.231.419.078
IN2PHARMA
Kerkstraat 108, 9050 GentOther information service activities
since 20262.388.528.493
2 parcels
Flanders 2 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
44362B0014/00G002 Flanders 3,095 m² 1 · 2,335 m² 9.2 m · 2 fl.
23038B0344/00G000
ProtectedCultural-historical landscape · MonumentKasteel Ter Loonst en omgevingSource ↗
Flanders 2,120 m² 1 · 39 m² 10.0 m · 3 fl.
Linked by address, not proof of ownership
Good to know
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
1 of these parcels carry protected heritage: expect extra rules on renovation or sale.

Structure & network

Connections & network

No current directors or connected companies found in the register.

Acquisitions and mergers

2 transactions
BE 0877.577.806merger by absorption · proposal · State Gazette act of 27-02-2026 (3 acts)
BE 0883.309.219merger by absorption · proposal · State Gazette act of 27-02-2026 (3 acts)

Public money · subsidies and aid

Flemish government

2024 · 1 entry · 285 EUR awarded · 285 EUR paid
Year Entries awardedpaid
2024 1 285 EUR285 EUR
Schemes
1 entry · 285 EUR · 285 EUR paid · Fonds voor Innoveren en Ondernemen

Similar companies · same sector, comparable size

Of 82,646 companies in sector 70200 we hold annual accounts for 52,627. 39,623 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Identification & contact

Identification
Legal formPublic limited company
Founded29-01-2008
Fiscal year end31-12
Activities, NACEBEL 2025
70200Business and other management consultancy
74999Other professional, scientific and technical activities
E-invoicing
Reachable via Peppol
Peppol ID 0208:0895730662

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 28 September 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.